Organogenesis Holdings (ORGO) EBT Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) EBT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 48.64% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -24.84% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -23.88% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1,578.91% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 45.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -342.95% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 62.03% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -267.87% |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | -165.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165.57% |
| Dec 31, 2025 | 518.62% |
| Sep 30, 2025 | 263.39% |
| Jun 30, 2025 | 18.61% |
| Mar 31, 2025 | -493.67% |
| Dec 31, 2024 | 670.88% |
| Sep 30, 2024 | -23.75% |
| Jun 30, 2024 | -258.41% |
| Mar 31, 2024 | 6.14% |
| Dec 31, 2023 | -120.52% |
| Sep 30, 2023 | 530.12% |
| Jun 30, 2023 | -17.93% |
| Mar 31, 2023 | -433.06% |
| Dec 31, 2022 | -53.66% |
| Sep 30, 2022 | -90.59% |
| Jun 30, 2022 | -47.18% |
| Mar 31, 2022 | -108.56% |
| Dec 31, 2021 | 0.95% |
| Sep 30, 2021 | -38.16% |
| Jun 30, 2021 | 512.03% |